Oral Tirzepatide

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist is a dual-action treatment for controlling blood sugar and weight loss.

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist is a dual-action treatment for controlling blood sugar and weight loss.

This treatment plan is an all-in-one flat rate physician consult and a single Tirzepatide prescription (as determined by your physician) delivered. Prescriptions are written at the physician’s discretion and are based on the results of your initial telemedicine consultation with your provider. There is no written or implied guarantee of any particular prescription for any particular period of time. Cancellation requests may be requested through your account in our secure portal.

Amble Health prescribes medications like Ozempic, Wegovy, or Zepbound, These are among the most effective weight loss medications on the market. Membership includes a provider consultation and prescription (if appropriate), access to GLP-1 medication, and the ongoing care and support you need to keep the weight off.

† Ozempic®, WeGovy®, Saxenda®, and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Amble Health is not affiliated with Novo Nordisk or Eli Lilly, and the compounded products offered by Amble are not produced by these companies. Compounded medications may be prescribed when appropriate based on patient medical need. While federal law allows the prescription of compounded drugs, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review.

For Important Safety Information Regarding Tirzepatide Products click here.